Prophase labs, inc. announces financial results for the year ended december 31, 2024

Company to accelerate be-smart commercialization as a cash-pay diagnostic significantly reduces overhead, improves margins heading into q2 2025 company to hold a conference call monday, march 31, 2025, at 11:00 am est garden city, ny, march 31, 2025 (globe newswire) -- prophase labs, inc. (nasdaq: prph), (the “company” or “prophase”), a next generation biotech, genomics and consumer products company, today reported its financial and operational results for the full-year ended december 31, 2024 and outlined strategic corporate developments aimed at realigning the company for sustained long-term growth, profitability, and strategic focus. ted karkus, ceo of prophase labs, will present to shareholders today, march 31, 2025, at 11:00 a.m.
PRPH Ratings Summary
PRPH Quant Ranking